GLP-1 & Metabolic Health
Weight Control
Browse prescription weight-management and metabolic medicines by active ingredient and brand. GLP-1 products may be temperature sensitive, so product authenticity, prescription suitability, cold-chain route and destination eligibility are reviewed before fulfilment.
What we review before supply
- A prescription and patient-specific review may be required.
- Cold-chain suitability is confirmed for temperature-sensitive products.
- Availability and import eligibility differ between destinations.
Weight Control catalogue
- Rybelsus 7mg (Oral Semaglutide)
Oral GLP-1 receptor agonist for glycemic control and metabolic weight management.
- Rybelsus 3mg (Oral Semaglutide)
Oral GLP-1 receptor agonist for glycemic control and metabolic weight management (starter dose).
- Rybelsus 14mg (Oral Semaglutide)
Oral GLP-1 receptor agonist for glycemic control and metabolic weight management (maintenance dose).
- Ozempic 0.25mg / 0.5mg (Semaglutide Injection)
Injectable GLP-1 receptor agonist. Supplied in a pre-filled pen. Requires 2-8°C cold chain transport.
- Ozempic 1mg (Semaglutide Injection)
Injectable GLP-1 receptor agonist (maintenance dose). Supplied in a pre-filled pen. Requires 2-8°C cold chain transport.
- Wegovy 2.4mg (Semaglutide Injection)
High-dose injectable GLP-1 receptor agonist specifically indicated for weight management. Requires 2-8°C cold chain transport.
- Tirzepatide Injection — Request Access
Prescription GLP-1/GIP therapy. Exact strength, brand, cold-chain route and patient eligibility are confirmed during clinical and supply review.
- Semaglutide Injection — Request Access
Prescription GLP-1 therapy. Strength, indication, authentic supply and temperature-controlled delivery require case review.
- Semaglutide Oral Tablets — Request Access
Prescription GLP-1 therapy in oral form. Available strengths (3mg, 7mg, 14mg) and supply availability are confirmed during review.
Product information is for catalogue and sourcing purposes and is not medical advice. A prescription and destination-specific approval may be required.